← Back to Discover
NEXTBio Capital Management LP
Period ended Sep 30, 2026 · Latest filing Nov 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $234,373,442
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- PROTAGONIST THERAPEUTICS INC · COM · 74366E102 · shares: $30,901,826
- SHATTUCK LABS INC · COM · 82024L103 · shares: $25,420,513
- COMPASS PATHWAYS PLC · SPONSORED ADS · 20451W101 · shares: $22,090,442
- RHYTHM PHARMACEUTICALS INC · COM · 76243J105 · shares: $12,545,338
- VOR BIOPHARMA INC · COM NEW · 929033207 · shares: $11,847,363
- PHARVARIS N V · COM · N69605108 · shares: $11,817,349
- XENON PHARMACEUTICALS INC · COM · 98420N105 · shares: $11,537,268
- ZENAS BIOPHARMA INC · COM · 98937L105 · shares: $11,509,070
- PALVELLA THERAPEUTICS INC NE · COM · 697947109 · shares: $11,090,813
- STRUCTURE THERAPEUTICS INC · SPONSORED ADS · 86366E106 · shares: $9,771,750
Reported holdings
25 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 219,333 shares | $30,901,826 |
| SHATTUCK LABS INC | COM | 82024L103 | — | 3,727,348 shares | $25,420,513 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 1,775,759 shares | $22,090,442 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 131,758 shares | $12,545,338 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 620,931 shares | $11,847,363 |
| PHARVARIS N V | COM | N69605108 | — | 372,552 shares | $11,817,349 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 310,225 shares | $11,537,268 |
| ZENAS BIOPHARMA INC | COM | 98937L105 | — | 426,736 shares | $11,509,070 |
| PALVELLA THERAPEUTICS INC NE | COM | 697947109 | — | 80,409 shares | $11,090,813 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 312,496 shares | $9,771,750 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 684,476 shares | $9,219,892 |
| ENTERA BIO LTD | SHS | M40527109 | — | 2,923,937 shares | $8,508,657 |
| VERASTEM INC | COM NEW | 92337C203 | — | 906,742 shares | $7,299,273 |
| INVENTIVA SA | ADS | 46124U107 | — | 1,787,984 shares | $6,597,661 |
| ZAI LAB LTD | ADR | 98887Q104 | — | 238,362 shares | $6,278,455 |
| VAXCYTE INC | COM | 92243G108 | — | 107,223 shares | $6,100,989 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 178,036 shares | $5,700,713 |
| KORSANA BIOSCIENCES INC | COM | 23255M303 | — | 175,403 shares | $5,612,896 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 372,856 shares | $5,439,969 |
| BLOSSOMHILL THERAPEUTICS INC | COM | 095130100 | — | 250,000 shares | $4,660,000 |
| DISC MEDICINE INC | COM | 254604101 | — | 52,655 shares | $3,446,796 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 69,549 shares | $2,669,291 |
| ADARX PHARMACEUTICALS INC | COM | 00654F105 | — | 100,000 shares | $1,994,000 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 111,455 shares | $1,329,658 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 119,063 shares | $983,460 |